Abstract
Here we describe two families with retinitis pigmentosa, a hereditary neurodegeneration of rod and cone photoreceptors in the retina. Affected family members were homozygous for loss-of-function mutations in IDH3B, encoding the beta-subunit of NAD-specific isocitrate dehydrogenase (NAD-IDH, or IDH3), which is believed to catalyze the oxidation of isocitrate to alpha-ketoglutarate in the citric acid cycle. Cells from affected individuals had a substantial reduction of NAD-IDH activity, with about a 300-fold increase in the K(m) for NAD. NADP-specific isocitrate dehydrogenase (NADP-IDH, or IDH2), an enzyme that catalyzes the same reaction, was normal in affected individuals, and they had no health problems associated with the enzyme deficiency except for retinitis pigmentosa. These findings support the hypothesis that mitochondrial NADP-IDH, rather than NAD-IDH, serves as the main catalyst for this reaction in the citric acid cycle outside the retina, and that the retina has a particular requirement for NAD-IDH.
MeSH Terms
Case-Control Studies
Citric Acid Cycle/genetics
Female
Genes, Recessive
Humans
Isocitrate Dehydrogenase/genetics,metabolism
Isocitrates/metabolism
Lymphocytes/enzymology
Male
NAD/metabolism
NADP/metabolism
RNA, Messenger/genetics,metabolism
Retinitis Pigmentosa/enzymology,genetics
Reverse Transcriptase Polymerase Chain Reaction
Chemicals
Isocitrates
RNA, Messenger
NAD
NADP
isocitric acid
Isocitrate Dehydrogenase
Authors & Affiliations
6 authors, click to expand affiliations / ORCID
Hartong Dyonne T
Ocular Molecular Genetics Institute, Harvard Medical School, Massachusetts Eye and Ear Infirmary, 243 Charles Street, Boston, Massachusetts 02114, USA.
Dange Mayura
McGee Terri L
Berson Eliot L
Dryja Thaddeus P
Colman Roberta F
References (20)
20 references, click to expand
-
Regulation of the human inosine monophosphate dehydrogenase type I gene. Utilization of alternative promoters.
J Biol Chem. 1997 Feb 14;272(7):4458-66
PMID: 9020170
-
Chemical characterization of distinct subunits of pig heart DPN-specific isocitrate dehydrogenase.
J Biol Chem. 1980 Sep 25;255(18):8859-64
PMID: 7410398
-
Using microarrays to facilitate positional cloning: identification of tomosyn as an inhibitor of neurosecretion.
PLoS Genet. 2005 Jul;1(1):6-16
PMID: 16103915
-
The proton-translocating nicotinamide-adenine dinucleotide (phosphate) transhydrogenase of rat liver mitochondria.
Biochem J. 1973 Mar;132(3):571-85
PMID: 4146799
-
Nonsense-mediated decay microarray analysis identifies mutations of EPHB2 in human prostate cancer.
Nat Genet. 2004 Sep;36(9):979-83
PMID: 15300251
-
Activities of NAD-specific and NADP-specific isocitrate dehydrogenases in rat-liver mitochondria. Studies with D-threo-alpha-methylisocitrate.
Eur J Biochem. 1979 Jun;97(1):283-95
PMID: 38961
-
Interference of nonsense mutations with eukaryotic messenger RNA stability.
Proc Natl Acad Sci U S A. 1979 Oct;76(10):5134-7
PMID: 388431
-
Model-based analysis of oligonucleotide arrays: model validation, design issues and standard error application.
Genome Biol. 2001;2(8):RESEARCH0032
PMID: 11532216
-
Evaluation by mutagenesis of the importance of 3 arginines in alpha, beta, and gamma subunits of human NAD-dependent isocitrate dehydrogenase.
J Biol Chem. 2003 Dec 26;278(52):52146-53
PMID: 14555658
-
Assignment of mitochondrial NAD(+)-specific isocitrate dehydrogenase beta subunit gene (IDH3B) to human chromosome band 20p13 by in situ hybridization and radiation hybrid mapping.
Cytogenet Cell Genet. 1999;86(3-4):240-1
PMID: 10575215
-
Mutations in the pre-mRNA splicing factor gene PRPC8 in autosomal dominant retinitis pigmentosa (RP13).
Hum Mol Genet. 2001 Jul 15;10(15):1555-62
PMID: 11468273
-
Positional cloning of the gene for X-linked retinitis pigmentosa 2.
Nat Genet. 1998 Aug;19(4):327-32
PMID: 9697692
-
Diphosphopyridine nucleotide dependent isocitrate dehydrogenase from pig heart. Charactgerization of the active substrate and modes of regulation.
Biochemistry. 1972 Apr 11;11(8):1501-8
PMID: 4336621
-
Identifying retinal disease genes: how far have we come, how far do we have to go?
Novartis Found Symp. 2004;255:17-27; discussion 27-36, 177-8
PMID: 14750594
-
A strategy for disease gene identification through nonsense-mediated mRNA decay inhibition.
Nat Biotechnol. 2001 May;19(5):434-9
PMID: 11329012
-
Retinitis pigmentosa.
Lancet. 2006 Nov 18;368(9549):1795-809
PMID: 17113430
-
A gene (RPGR) with homology to the RCC1 guanine nucleotide exchange factor is mutated in X-linked retinitis pigmentosa (RP3).
Nat Genet. 1996 May;13(1):35-42
PMID: 8673101
-
Mutations in HPRP3, a third member of pre-mRNA splicing factor genes, implicated in autosomal dominant retinitis pigmentosa.
Hum Mol Genet. 2002 Jan 1;11(1):87-92
PMID: 11773002
-
A human homolog of yeast pre-mRNA splicing gene, PRP31, underlies autosomal dominant retinitis pigmentosa on chromosome 19q13.4 (RP11).
Mol Cell. 2001 Aug;8(2):375-81
PMID: 11545739
-
Physiological roles of nicotinamide nucleotide transhydrogenase.
Biochem J. 1988 Aug 15;254(1):1-10
PMID: 3052428